Ryeqo for fibroids and endometriosis: blood clotting study
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how Ryeqo, a medicine for uterine fibroids and endometriosis, affects blood clotting in women taking it. It aims to make sure the treatment is safe for your body's clotting system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman prescribed Ryeqo for uterine fibroids or endometriosis.
- You are 18 years or older.
- You can speak and read French.
- You have not used birth control pills, patches, rings, or estrogen pills in the last 3 months.
- You have not used the shot Depo-Provera or nomegestrol acetate in the last 3 months.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This study tests how well a long-term treatment using a relugolix combination tablet helps protect bone density in women who have uterine fibroids or endometriosis. It may help people who are at risk of bone thinning while receiving hormone-related symptom treatment.
This trial tests if the drug letrozole can improve symptoms like heavy bleeding and pelvic pain caused by uterine fibroids. You must be premenopausal with moderate to severe symptoms and not have very large fibroids or certain other conditions.
This trial tests whether an oral medication called rimegepant can reduce moderate to severe pain caused by endometriosis. Rimegepant is a pill that targets a protein involved in pain signaling, and it may offer a new option for managing endometriosis symptoms.
This study tests whether an ultrasound can show how fibroids (benign uterine growths) change during treatment with a medication called Relugolix (combined with estrogen and progestin). It's for women who have heavy bleeding and want to know if the medication can shrink their fibroids.
This trial tests a new medicine called KLH-2109 for women who have uterine fibroids that cause heavy menstrual bleeding. The goal is to see if the medicine can reduce bleeding and improve symptoms.
Hear when a new Uterine Fibroid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.